Alterations in homologous recombination repair genes in prostate
Por um escritor misterioso
Descrição
SPOP mutation leads to genomic instability in prostate cancer
DNA double-strand break repair by homologous recombination. Coordinated
Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer - eBioMedicine
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations
Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?
Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer
Exploiting the homologous recombination DNA repair network for targeted cancer therapy
Prostate cancer and PARP inhibitors: progress and challenges, Journal of Hematology & Oncology
ASCO 2023: Presence of Somatic/Germline Homologous Recombination Repair Mutations and Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Receiving First‑line Treatment Stratified by BRCA Status
Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology
Clinical implications of homologous recombination repair mutations in prostate cancer - Cresta Morgado - 2022 - The Prostate - Wiley Online Library
The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies - Rimar - 2017 - Cancer - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)